Yahoo Web Search

Search results

1. • 

     Earnings call: Nektar Therapeutics optimistic on REZPEG and pipeline progress By Investing.com

     Investing.com· 1 day ago

     Nektar Therapeutics (NASDAQ:NKTR) reported a productive first quarter of 2024, focusing on their...

2. • 

     Nektar's (NKTR) Q1 Earnings and Revenues Surpass Estimates

     Zacks via Yahoo Finance· 1 day ago

     Zacks Rank & Stocks to Consider Nektar currently carries a Zacks Rank #4 (Sell). Nektar Therapeutics...

3. • Nektar Therapeutics (NKTR) First Quarter 2024 Earnings Overview

     Guru Focus· 1 day ago

     On May 9, 2024, Nektar Therapeutics (NKTR, Financial) disclosed its financial results for the first quarter ended March 31, 2024, through an 8-K filing.

4. • 

     Jefferies raises Nektar Therapeutics stock target, maintains hold By Investing.com

     Investing.com· 1 day ago

     Jefferies, a well-known investment firm, has increased its price target on shares of Nektar ...

5. • Nektar: Q1 Earnings Snapshot

     Santa Maria Times· 2 days ago

     SAN FRANCISCO (AP) — SAN FRANCISCO (AP) — Nektar Therapeutics (NKTR) on Thursday reported a loss of $36.8 million in its first quarter.

6. • Securities lawsuits premised on short-seller reports come up short

     Reuters· 4 days ago

     Short-seller reports frequently lead to stock price drops that give rise to securities class action lawsuits. Plaintiffs who rely on short-seller reports ...

7. • Small Business - The Brewton Standard | The Brewton Standard

     The Brewton Standard· 3 days ago

     $398 million in first quarter global net product sales FDA review ongoing for CIDP sBLA with PDUFA target action date of June 21, 2024 On track to submit filing for pre-filled syringe (PFS) in second quarter 2024 Management to host conference